Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petros I Rafailidis

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|March 14, 2014
Case 38-2013: A man with fever and lymphadenopathyPetros I Rafailidis
Expert Review of Anti-Infective Therapy|June 21, 2021
Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteriaPetros I Rafailidis, Diamantis Kofteridis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2015
Editorial Commentary: Fosfomycin: The Current Status of the DrugMatthew E Falagas, Petros I Rafailidis
European Journal of Internal Medicine|May 13, 2008
Discordance between data acquired by history and findings of physical examination: a phenomenal paradoxPetros I Rafailidis, Matthew E Falagas
Shock (Augusta, Ga.)|May 17, 2007
When to include polymyxins in the empirical antibiotic regimen in critically ill patients with fever? A decision analysis approachMatthew E Falagas, Petros I Rafailidis
Current Opinion in Infectious Diseases|September 27, 2014
Options for treating carbapenem-resistant EnterobacteriaceaePetros I Rafailidis, Matthew E Falagas
Expert Review of Anti-Infective Therapy|June 23, 2020
Benefits of prolonged infusion of beta-lactam antibiotics in patients with sepsis: personal perspectivesPetros I Rafailidis, Matthew E Falagas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2012
Colistin in ventilator-associated pneumoniaM E Falagas, Petros I Rafailidis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2009
Nephrotoxicity of colistin: new insight into an old antibioticMatthew E Falagas, Petros I Rafailidis
Critical Care (London, England)|June 5, 2007
Attributable mortality of Acinetobacter baumannii: no longer a controversial issueMatthew E Falagas, Petros I Rafailidis
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|March 14, 2014
Case 38-2013: A man with fever and lymphadenopathyPetros I Rafailidis
Expert Review of Anti-Infective Therapy|June 21, 2021
Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteriaPetros I Rafailidis, Diamantis Kofteridis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2015
Editorial Commentary: Fosfomycin: The Current Status of the DrugMatthew E Falagas, Petros I Rafailidis
European Journal of Internal Medicine|May 13, 2008
Discordance between data acquired by history and findings of physical examination: a phenomenal paradoxPetros I Rafailidis, Matthew E Falagas
Shock (Augusta, Ga.)|May 17, 2007
When to include polymyxins in the empirical antibiotic regimen in critically ill patients with fever? A decision analysis approachMatthew E Falagas, Petros I Rafailidis
Current Opinion in Infectious Diseases|September 27, 2014
Options for treating carbapenem-resistant EnterobacteriaceaePetros I Rafailidis, Matthew E Falagas
Expert Review of Anti-Infective Therapy|June 23, 2020
Benefits of prolonged infusion of beta-lactam antibiotics in patients with sepsis: personal perspectivesPetros I Rafailidis, Matthew E Falagas
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2012
Colistin in ventilator-associated pneumoniaM E Falagas, Petros I Rafailidis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2009
Nephrotoxicity of colistin: new insight into an old antibioticMatthew E Falagas, Petros I Rafailidis
Critical Care (London, England)|June 5, 2007
Attributable mortality of Acinetobacter baumannii: no longer a controversial issueMatthew E Falagas, Petros I Rafailidis
Pageof 9